
### [MONDO:0021054](http://purl.obolibrary.org/obo/MONDO_0021054)
**Label:** bone sarcoma

**Subclasses:** [MONDO:0002619](http://purl.obolibrary.org/obo/MONDO_0002619) (bone fibrosarcoma), [MONDO:0002618](http://purl.obolibrary.org/obo/MONDO_0002618) (malignant fibrous histiocytoma of bone), [MONDO:0016069](http://purl.obolibrary.org/obo/MONDO_0016069) (undifferentiated pleomorphic sarcoma), [MONDO:0003728](http://purl.obolibrary.org/obo/MONDO_0003728) (breast fibrosarcoma), [MONDO:0002617](http://purl.obolibrary.org/obo/MONDO_0002617) (bone angioendothelial sarcoma), [MONDO:0006817](http://purl.obolibrary.org/obo/MONDO_0006817) (juxtacortical osteosarcoma), [MONDO:0002677](http://purl.obolibrary.org/obo/MONDO_0002677) (conventional fibrosarcoma), [MONDO:0002676](http://purl.obolibrary.org/obo/MONDO_0002676) (adult fibrosarcoma), [MONDO:0002632](http://purl.obolibrary.org/obo/MONDO_0002632) (metachronous osteosarcoma of the bone), [MONDO:0004557](http://purl.obolibrary.org/obo/MONDO_0004557) (congenital fibrosarcoma), [MONDO:0002634](http://purl.obolibrary.org/obo/MONDO_0002634) (liposarcoma of bone), [MONDO:0002678](http://purl.obolibrary.org/obo/MONDO_0002678) (pediatric fibrosarcoma), [MONDO:0004435](http://purl.obolibrary.org/obo/MONDO_0004435) (liver fibrosarcoma), [MONDO:0003742](http://purl.obolibrary.org/obo/MONDO_0003742) (heart fibrosarcoma), [MONDO:0003720](http://purl.obolibrary.org/obo/MONDO_0003720) (kidney fibrosarcoma), [MONDO:0003882](http://purl.obolibrary.org/obo/MONDO_0003882) (central nervous system fibrosarcoma), [MONDO:0002631](http://purl.obolibrary.org/obo/MONDO_0002631) (conventional osteosarcoma), [MONDO:0003684](http://purl.obolibrary.org/obo/MONDO_0003684) (clear cell chondrosarcoma), [MONDO:0002630](http://purl.obolibrary.org/obo/MONDO_0002630) (small cell osteogenic sarcoma), [MONDO:0007300](http://purl.obolibrary.org/obo/MONDO_0007300) (cerebral sarcoma), [MONDO:0003680](http://purl.obolibrary.org/obo/MONDO_0003680) (periosteal chondrosarcoma), [MONDO:0004275](http://purl.obolibrary.org/obo/MONDO_0004275) (osteosarcoma arising in bone Paget's disease), [MONDO:0005164](http://purl.obolibrary.org/obo/MONDO_0005164) (fibrosarcoma (disease)), [MONDO:0006273](http://purl.obolibrary.org/obo/MONDO_0006273) (low grade fibromyxoid sarcoma with giant collagen Rosettes), [MONDO:0004050](http://purl.obolibrary.org/obo/MONDO_0004050) (telangiectatic osteogenic sarcoma), [MONDO:0006272](http://purl.obolibrary.org/obo/MONDO_0006272) (low grade fibromyxoid sarcoma), [MONDO:0011934](http://purl.obolibrary.org/obo/MONDO_0011934) (dermatofibrosarcoma protuberans), [MONDO:0006094](http://purl.obolibrary.org/obo/MONDO_0006094) (Askin tumor), [MONDO:0002629](http://purl.obolibrary.org/obo/MONDO_0002629) (bone osteosarcoma), [MONDO:0002625](http://purl.obolibrary.org/obo/MONDO_0002625) (Ewing sarcoma of bone), [MONDO:0002628](http://purl.obolibrary.org/obo/MONDO_0002628) (peripheral osteosarcoma), [MONDO:0002627](http://purl.obolibrary.org/obo/MONDO_0002627) (chondroblastic osteosarcoma), [MONDO:0004306](http://purl.obolibrary.org/obo/MONDO_0004306) (childhood intracortical osteosarcoma), [MONDO:0018271](http://purl.obolibrary.org/obo/MONDO_0018271) (peripheral primitive neuroectodermal tumor), [MONDO:0002624](http://purl.obolibrary.org/obo/MONDO_0002624) (bone leiomyosarcoma), [MONDO:0003895](http://purl.obolibrary.org/obo/MONDO_0003895) (periosteal osteogenic sarcoma), [MONDO:0002981](http://purl.obolibrary.org/obo/MONDO_0002981) (peripheral primitive neuroectodermal tumor of bone), [MONDO:0004028](http://purl.obolibrary.org/obo/MONDO_0004028) (small intestinal fibrosarcoma), [MONDO:0003654](http://purl.obolibrary.org/obo/MONDO_0003654) (childhood parosteal osteosarcoma), [MONDO:0004300](http://purl.obolibrary.org/obo/MONDO_0004300) (intracortical osteogenic sarcoma), [MONDO:0004301](http://purl.obolibrary.org/obo/MONDO_0004301) (fibrosarcomatous osteosarcoma), [MONDO:0002982](http://purl.obolibrary.org/obo/MONDO_0002982) (peripheral primitive neuroectodermal tumor of soft tissues), [MONDO:0006246](http://purl.obolibrary.org/obo/MONDO_0006246) (high grade surface osteosarcoma), [MONDO:0005013](http://purl.obolibrary.org/obo/MONDO_0005013) (dedifferentiated chondrosarcoma), [MONDO:0006287](http://purl.obolibrary.org/obo/MONDO_0006287) (malignancy in giant cell tumor of bone), [MONDO:0018219](http://purl.obolibrary.org/obo/MONDO_0018219) (giant cell tumor of bone (disease)), 

**Mapped go classes:** [GO:0006281](http://purl.obolibrary.org/obo/GO_0006281) (DNA repair), [GO:0016525](http://purl.obolibrary.org/obo/GO_0016525) (negative regulation of angiogenesis), [GO:0030031](http://purl.obolibrary.org/obo/GO_0030031) (cell projection assembly), [GO:0008104](http://purl.obolibrary.org/obo/GO_0008104) (protein localization), [GO:0003690](http://purl.obolibrary.org/obo/GO_0003690) (double-stranded DNA binding), [GO:0021554](http://purl.obolibrary.org/obo/GO_0021554) (optic nerve development), [GO:0003688](http://purl.obolibrary.org/obo/GO_0003688) (DNA replication origin binding), [GO:0045892](http://purl.obolibrary.org/obo/GO_0045892) (negative regulation of transcription, DNA-templated), [GO:0045893](http://purl.obolibrary.org/obo/GO_0045893) (positive regulation of transcription, DNA-templated), [GO:0046982](http://purl.obolibrary.org/obo/GO_0046982) (protein heterodimerization activity), [GO:0050679](http://purl.obolibrary.org/obo/GO_0050679) (positive regulation of epithelial cell proliferation), [GO:2000491](http://purl.obolibrary.org/obo/GO_2000491) (positive regulation of hepatic stellate cell activation), [GO:0048008](http://purl.obolibrary.org/obo/GO_0048008) (platelet-derived growth factor receptor signaling pathway), [GO:0004672](http://purl.obolibrary.org/obo/GO_0004672) (protein kinase activity), [GO:0009202](http://purl.obolibrary.org/obo/GO_0009202) (deoxyribonucleoside triphosphate biosynthetic process), [GO:0021782](http://purl.obolibrary.org/obo/GO_0021782) (glial cell development), [GO:0004674](http://purl.obolibrary.org/obo/GO_0004674) (protein serine/threonine kinase activity), [GO:0006974](http://purl.obolibrary.org/obo/GO_0006974) (cellular response to DNA damage stimulus), [GO:0000077](http://purl.obolibrary.org/obo/GO_0000077) (DNA damage checkpoint), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0005516](http://purl.obolibrary.org/obo/GO_0005516) (calmodulin binding), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0005518](http://purl.obolibrary.org/obo/GO_0005518) (collagen binding), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0071363](http://purl.obolibrary.org/obo/GO_0071363) (cellular response to growth factor stimulus), [GO:0010544](http://purl.obolibrary.org/obo/GO_0010544) (negative regulation of platelet activation), [GO:0044212](http://purl.obolibrary.org/obo/GO_0044212) (transcription regulatory region DNA binding), [GO:0045786](http://purl.obolibrary.org/obo/GO_0045786) (negative regulation of cell cycle), [GO:0045787](http://purl.obolibrary.org/obo/GO_0045787) (positive regulation of cell cycle), [GO:0097193](http://purl.obolibrary.org/obo/GO_0097193) (intrinsic apoptotic signaling pathway), [GO:0009411](http://purl.obolibrary.org/obo/GO_0009411) (response to UV), [GO:1904754](http://purl.obolibrary.org/obo/GO_1904754) (positive regulation of vascular associated smooth muscle cell migration), [GO:0007596](http://purl.obolibrary.org/obo/GO_0007596) (blood coagulation), [GO:0043249](http://purl.obolibrary.org/obo/GO_0043249) (erythrocyte maturation), [GO:0000166](http://purl.obolibrary.org/obo/GO_0000166) (nucleotide binding), [GO:0060947](http://purl.obolibrary.org/obo/GO_0060947) (cardiac vascular smooth muscle cell differentiation), [GO:0051781](http://purl.obolibrary.org/obo/GO_0051781) (positive regulation of cell division), [GO:0051782](http://purl.obolibrary.org/obo/GO_0051782) (negative regulation of cell division), [GO:0048146](http://purl.obolibrary.org/obo/GO_0048146) (positive regulation of fibroblast proliferation), [GO:0010512](http://purl.obolibrary.org/obo/GO_0010512) (negative regulation of phosphatidylinositol biosynthetic process), [GO:2000134](http://purl.obolibrary.org/obo/GO_2000134) (negative regulation of G1/S transition of mitotic cell cycle), [GO:0072126](http://purl.obolibrary.org/obo/GO_0072126) (positive regulation of glomerular mesangial cell proliferation), [GO:2000379](http://purl.obolibrary.org/obo/GO_2000379) (positive regulation of reactive oxygen species metabolic process), [GO:0006270](http://purl.obolibrary.org/obo/GO_0006270) (DNA replication initiation), [GO:1905176](http://purl.obolibrary.org/obo/GO_1905176) (positive regulation of vascular smooth muscle cell dedifferentiation), [GO:0031571](http://purl.obolibrary.org/obo/GO_0031571) (mitotic G1 DNA damage checkpoint), [GO:0006275](http://purl.obolibrary.org/obo/GO_0006275) (regulation of DNA replication), [GO:0048821](http://purl.obolibrary.org/obo/GO_0048821) (erythrocyte development), [GO:0003682](http://purl.obolibrary.org/obo/GO_0003682) (chromatin binding), [GO:0003684](http://purl.obolibrary.org/obo/GO_0003684) (damaged DNA binding), [GO:0072593](http://purl.obolibrary.org/obo/GO_0072593) (reactive oxygen species metabolic process), [GO:0003677](http://purl.obolibrary.org/obo/GO_0003677) (DNA binding), [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0010526](http://purl.obolibrary.org/obo/GO_0010526) (negative regulation of transposition, RNA-mediated), [GO:0005739](http://purl.obolibrary.org/obo/GO_0005739) (mitochondrion), [GO:0097756](http://purl.obolibrary.org/obo/GO_0097756) (negative regulation of blood vessel diameter), [GO:0001938](http://purl.obolibrary.org/obo/GO_0001938) (positive regulation of endothelial cell proliferation), [GO:0016740](http://purl.obolibrary.org/obo/GO_0016740) (transferase activity), [GO:0007050](http://purl.obolibrary.org/obo/GO_0007050) (cell cycle arrest), [GO:0061098](http://purl.obolibrary.org/obo/GO_0061098) (positive regulation of protein tyrosine kinase activity), [GO:0045840](http://purl.obolibrary.org/obo/GO_0045840) (positive regulation of mitotic nuclear division), [GO:0008024](http://purl.obolibrary.org/obo/GO_0008024) (cyclin/CDK positive transcription elongation factor complex), [GO:0060445](http://purl.obolibrary.org/obo/GO_0060445) (branching involved in salivary gland morphogenesis), [GO:0060326](http://purl.obolibrary.org/obo/GO_0060326) (cell chemotaxis), [GO:0005667](http://purl.obolibrary.org/obo/GO_0005667) (transcription factor complex), [GO:0000781](http://purl.obolibrary.org/obo/GO_0000781) (chromosome, telomeric region), [GO:0031954](http://purl.obolibrary.org/obo/GO_0031954) (positive regulation of protein autophosphorylation), [GO:0002039](http://purl.obolibrary.org/obo/GO_0002039) (p53 binding), [GO:0051289](http://purl.obolibrary.org/obo/GO_0051289) (protein homotetramerization), [GO:0005669](http://purl.obolibrary.org/obo/GO_0005669) (transcription factor TFIID complex), [GO:0051726](http://purl.obolibrary.org/obo/GO_0051726) (regulation of cell cycle), [GO:0071456](http://purl.obolibrary.org/obo/GO_0071456) (cellular response to hypoxia), [GO:0010332](http://purl.obolibrary.org/obo/GO_0010332) (response to gamma radiation), [GO:0045737](http://purl.obolibrary.org/obo/GO_0045737) (positive regulation of cyclin-dependent protein serine/threonine kinase activity), [GO:0042462](http://purl.obolibrary.org/obo/GO_0042462) (eye photoreceptor cell development), [GO:0043552](http://purl.obolibrary.org/obo/GO_0043552) (positive regulation of phosphatidylinositol 3-kinase activity), [GO:0045977](http://purl.obolibrary.org/obo/GO_0045977) (positive regulation of mitotic cell cycle, embryonic), [GO:0000785](http://purl.obolibrary.org/obo/GO_0000785) (chromatin), [GO:0016322](http://purl.obolibrary.org/obo/GO_0016322) (neuron remodeling), [GO:0016323](http://purl.obolibrary.org/obo/GO_0016323) (basolateral plasma membrane), [GO:0035189](http://purl.obolibrary.org/obo/GO_0035189) (Rb-E2F complex), [GO:0007275](http://purl.obolibrary.org/obo/GO_0007275) (multicellular organism development), [GO:1902894](http://purl.obolibrary.org/obo/GO_1902894) (negative regulation of pri-miRNA transcription by RNA polymerase II), [GO:0044773](http://purl.obolibrary.org/obo/GO_0044773) (mitotic DNA damage checkpoint), [GO:0045743](http://purl.obolibrary.org/obo/GO_0045743) (positive regulation of fibroblast growth factor receptor signaling pathway), [GO:0045740](http://purl.obolibrary.org/obo/GO_0045740) (positive regulation of DNA replication), [GO:1902895](http://purl.obolibrary.org/obo/GO_1902895) (positive regulation of pri-miRNA transcription by RNA polymerase II), [GO:0043565](http://purl.obolibrary.org/obo/GO_0043565) (sequence-specific DNA binding), [GO:0004683](http://purl.obolibrary.org/obo/GO_0004683) (calmodulin-dependent protein kinase activity), [GO:0003104](http://purl.obolibrary.org/obo/GO_0003104) (positive regulation of glomerular filtration), [GO:0006978](http://purl.obolibrary.org/obo/GO_0006978) (DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator), [GO:0003347](http://purl.obolibrary.org/obo/GO_0003347) (epicardial cell to mesenchymal cell transition), [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding), [GO:1904707](http://purl.obolibrary.org/obo/GO_1904707) (positive regulation of vascular smooth muscle cell proliferation), [GO:0034644](http://purl.obolibrary.org/obo/GO_0034644) (cellular response to UV), [GO:2000298](http://purl.obolibrary.org/obo/GO_2000298) (regulation of Rho-dependent protein serine/threonine kinase activity), [GO:0031012](http://purl.obolibrary.org/obo/GO_0031012) (extracellular matrix), [GO:0014911](http://purl.obolibrary.org/obo/GO_0014911) (positive regulation of smooth muscle cell migration), [GO:0016310](http://purl.obolibrary.org/obo/GO_0016310) (phosphorylation), [GO:0042802](http://purl.obolibrary.org/obo/GO_0042802) (identical protein binding), [GO:0042803](http://purl.obolibrary.org/obo/GO_0042803) (protein homodimerization activity), [GO:0007283](http://purl.obolibrary.org/obo/GO_0007283) (spermatogenesis), [GO:0008134](http://purl.obolibrary.org/obo/GO_0008134) (transcription factor binding), [GO:0042246](http://purl.obolibrary.org/obo/GO_0042246) (tissue regeneration), [GO:0007601](http://purl.obolibrary.org/obo/GO_0007601) (visual perception), [GO:1900127](http://purl.obolibrary.org/obo/GO_1900127) (positive regulation of hyaluronan biosynthetic process), [GO:0007049](http://purl.obolibrary.org/obo/GO_0007049) (cell cycle), [GO:0060216](http://purl.obolibrary.org/obo/GO_0060216) (definitive hemopoiesis), [GO:0005657](http://purl.obolibrary.org/obo/GO_0005657) (replication fork), [GO:0048478](http://purl.obolibrary.org/obo/GO_0048478) (replication fork protection), [GO:0070374](http://purl.obolibrary.org/obo/GO_0070374) (positive regulation of ERK1 and ERK2 cascade), [GO:0030036](http://purl.obolibrary.org/obo/GO_0030036) (actin cytoskeleton organization), [GO:0016301](http://purl.obolibrary.org/obo/GO_0016301) (kinase activity), [GO:0061298](http://purl.obolibrary.org/obo/GO_0061298) (retina vasculature development in camera-type eye), [GO:0014068](http://purl.obolibrary.org/obo/GO_0014068) (positive regulation of phosphatidylinositol 3-kinase signaling), [GO:0038033](http://purl.obolibrary.org/obo/GO_0038033) (positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway), [GO:0042770](http://purl.obolibrary.org/obo/GO_0042770) (signal transduction in response to DNA damage), [GO:0048514](http://purl.obolibrary.org/obo/GO_0048514) (blood vessel morphogenesis), [GO:0042771](http://purl.obolibrary.org/obo/GO_0042771) (intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator), [GO:0030425](http://purl.obolibrary.org/obo/GO_0030425) (dendrite), [GO:0032967](http://purl.obolibrary.org/obo/GO_0032967) (positive regulation of collagen biosynthetic process), [GO:0035556](http://purl.obolibrary.org/obo/GO_0035556) (intracellular signal transduction), [GO:0035793](http://purl.obolibrary.org/obo/GO_0035793) (positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway), [GO:0035791](http://purl.obolibrary.org/obo/GO_0035791) (platelet-derived growth factor receptor-beta signaling pathway), [GO:0048407](http://purl.obolibrary.org/obo/GO_0048407) (platelet-derived growth factor binding), [GO:0007416](http://purl.obolibrary.org/obo/GO_0007416) (synapse assembly), [GO:0051496](http://purl.obolibrary.org/obo/GO_0051496) (positive regulation of stress fiber assembly), [GO:0043406](http://purl.obolibrary.org/obo/GO_0043406) (positive regulation of MAP kinase activity), [GO:0031065](http://purl.obolibrary.org/obo/GO_0031065) (positive regulation of histone deacetylation), [GO:0008285](http://purl.obolibrary.org/obo/GO_0008285) (negative regulation of cell proliferation), [GO:0008284](http://purl.obolibrary.org/obo/GO_0008284) (positive regulation of cell proliferation), [GO:0090398](http://purl.obolibrary.org/obo/GO_0090398) (cellular senescence), [GO:0005576](http://purl.obolibrary.org/obo/GO_0005576) (extracellular region), [GO:0060664](http://purl.obolibrary.org/obo/GO_0060664) (epithelial cell proliferation involved in salivary gland morphogenesis), [GO:0045944](http://purl.obolibrary.org/obo/GO_0045944) (positive regulation of transcription by RNA polymerase II), [GO:0001892](http://purl.obolibrary.org/obo/GO_0001892) (embryonic placenta development), [GO:0043525](http://purl.obolibrary.org/obo/GO_0043525) (positive regulation of neuron apoptotic process), [GO:0048661](http://purl.obolibrary.org/obo/GO_0048661) (positive regulation of smooth muscle cell proliferation), [GO:0007507](http://purl.obolibrary.org/obo/GO_0007507) (heart development), [GO:0050730](http://purl.obolibrary.org/obo/GO_0050730) (regulation of peptidyl-tyrosine phosphorylation), [GO:0003700](http://purl.obolibrary.org/obo/GO_0003700) (DNA binding transcription factor activity), [GO:0001525](http://purl.obolibrary.org/obo/GO_0001525) (angiogenesis), [GO:2000779](http://purl.obolibrary.org/obo/GO_2000779) (regulation of double-strand break repair), [GO:0051262](http://purl.obolibrary.org/obo/GO_0051262) (protein tetramerization), [GO:0032147](http://purl.obolibrary.org/obo/GO_0032147) (activation of protein kinase activity), [GO:0032148](http://purl.obolibrary.org/obo/GO_0032148) (activation of protein kinase B activity), [GO:0050731](http://purl.obolibrary.org/obo/GO_0050731) (positive regulation of peptidyl-tyrosine phosphorylation), [GO:0035655](http://purl.obolibrary.org/obo/GO_0035655) (interleukin-18-mediated signaling pathway), [GO:0031290](http://purl.obolibrary.org/obo/GO_0031290) (retinal ganglion cell axon guidance), [GO:0038001](http://purl.obolibrary.org/obo/GO_0038001) (paracrine signaling), [GO:0043410](http://purl.obolibrary.org/obo/GO_0043410) (positive regulation of MAPK cascade), [GO:0005102](http://purl.obolibrary.org/obo/GO_0005102) (receptor binding), [GO:0043536](http://purl.obolibrary.org/obo/GO_0043536) (positive regulation of blood vessel endothelial cell migration), [GO:0090280](http://purl.obolibrary.org/obo/GO_0090280) (positive regulation of calcium ion import), [GO:0042326](http://purl.obolibrary.org/obo/GO_0042326) (negative regulation of phosphorylation), [GO:1903392](http://purl.obolibrary.org/obo/GO_1903392) (negative regulation of adherens junction organization), [GO:0018108](http://purl.obolibrary.org/obo/GO_0018108) (peptidyl-tyrosine phosphorylation), [GO:0070528](http://purl.obolibrary.org/obo/GO_0070528) (protein kinase C signaling), [GO:0016604](http://purl.obolibrary.org/obo/GO_0016604) (nuclear body), [GO:0060041](http://purl.obolibrary.org/obo/GO_0060041) (retina development in camera-type eye), [GO:1904899](http://purl.obolibrary.org/obo/GO_1904899) (positive regulation of hepatic stellate cell proliferation), [GO:0042056](http://purl.obolibrary.org/obo/GO_0042056) (chemoattractant activity), [GO:0043025](http://purl.obolibrary.org/obo/GO_0043025) (neuronal cell body), [GO:0032091](http://purl.obolibrary.org/obo/GO_0032091) (negative regulation of protein binding), [GO:0072264](http://purl.obolibrary.org/obo/GO_0072264) (metanephric glomerular endothelium development), [GO:0072262](http://purl.obolibrary.org/obo/GO_0072262) (metanephric glomerular mesangial cell proliferation involved in metanephros development), [GO:0006914](http://purl.obolibrary.org/obo/GO_0006914) (autophagy), [GO:0060729](http://purl.obolibrary.org/obo/GO_0060729) (intestinal epithelial structure maintenance), [GO:0006915](http://purl.obolibrary.org/obo/GO_0006915) (apoptotic process), [GO:0016176](http://purl.obolibrary.org/obo/GO_0016176) (superoxide-generating NADPH oxidase activator activity), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:1905064](http://purl.obolibrary.org/obo/GO_1905064) (negative regulation of vascular smooth muscle cell differentiation), [GO:0005161](http://purl.obolibrary.org/obo/GO_0005161) (platelet-derived growth factor receptor binding), [GO:0061484](http://purl.obolibrary.org/obo/GO_0061484) (hematopoietic stem cell homeostasis), [GO:0042981](http://purl.obolibrary.org/obo/GO_0042981) (regulation of apoptotic process), [GO:0006139](http://purl.obolibrary.org/obo/GO_0006139) (nucleobase-containing compound metabolic process), [GO:0043280](http://purl.obolibrary.org/obo/GO_0043280) (positive regulation of cysteine-type endopeptidase activity involved in apoptotic process), [GO:0010629](http://purl.obolibrary.org/obo/GO_0010629) (negative regulation of gene expression), [GO:0048730](http://purl.obolibrary.org/obo/GO_0048730) (epidermis morphogenesis), [GO:0072255](http://purl.obolibrary.org/obo/GO_0072255) (metanephric glomerular mesangial cell development), [GO:0010628](http://purl.obolibrary.org/obo/GO_0010628) (positive regulation of gene expression), [GO:0006929](http://purl.obolibrary.org/obo/GO_0006929) (substrate-dependent cell migration), [GO:0018105](http://purl.obolibrary.org/obo/GO_0018105) (peptidyl-serine phosphorylation), [GO:0050921](http://purl.obolibrary.org/obo/GO_0050921) (positive regulation of chemotaxis), [GO:0030336](http://purl.obolibrary.org/obo/GO_0030336) (negative regulation of cell migration), [GO:0018107](http://purl.obolibrary.org/obo/GO_0018107) (peptidyl-threonine phosphorylation), [GO:0030335](http://purl.obolibrary.org/obo/GO_0030335) (positive regulation of cell migration), [GO:0008083](http://purl.obolibrary.org/obo/GO_0008083) (growth factor activity), [GO:0010165](http://purl.obolibrary.org/obo/GO_0010165) (response to X-ray), [GO:0045907](http://purl.obolibrary.org/obo/GO_0045907) (positive regulation of vasoconstriction), [GO:0009611](http://purl.obolibrary.org/obo/GO_0009611) (response to wounding), [GO:0006468](http://purl.obolibrary.org/obo/GO_0006468) (protein phosphorylation), [GO:0000122](http://purl.obolibrary.org/obo/GO_0000122) (negative regulation of transcription by RNA polymerase II), [GO:0004713](http://purl.obolibrary.org/obo/GO_0004713) (protein tyrosine kinase activity), [GO:0004712](http://purl.obolibrary.org/obo/GO_0004712) (protein serine/threonine/tyrosine kinase activity), [GO:0001568](http://purl.obolibrary.org/obo/GO_0001568) (blood vessel development), [GO:2000573](http://purl.obolibrary.org/obo/GO_2000573) (positive regulation of DNA biosynthetic process), [GO:1902262](http://purl.obolibrary.org/obo/GO_1902262) (apoptotic process involved in blood vessel morphogenesis), [GO:2000591](http://purl.obolibrary.org/obo/GO_2000591) (positive regulation of metanephric mesenchymal cell migration), [GO:0006351](http://purl.obolibrary.org/obo/GO_0006351) (transcription, DNA-templated), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0060978](http://purl.obolibrary.org/obo/GO_0060978) (angiogenesis involved in coronary vascular morphogenesis), [GO:0009986](http://purl.obolibrary.org/obo/GO_0009986) (cell surface), [GO:0006357](http://purl.obolibrary.org/obo/GO_0006357) (regulation of transcription by RNA polymerase II), [GO:0051597](http://purl.obolibrary.org/obo/GO_0051597) (response to methylmercury), [GO:0031647](http://purl.obolibrary.org/obo/GO_0031647) (regulation of protein stability), [GO:0002548](http://purl.obolibrary.org/obo/GO_0002548) (monocyte chemotaxis), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0043065](http://purl.obolibrary.org/obo/GO_0043065) (positive regulation of apoptotic process), [GO:0034599](http://purl.obolibrary.org/obo/GO_0034599) (cellular response to oxidative stress), [GO:0071506](http://purl.obolibrary.org/obo/GO_0071506) (cellular response to mycophenolic acid), 

**Class expressions from DL-Learner:**

- Thing 54.95%
- [GO:0071456](http://purl.obolibrary.org/obo/GO_0071456) (cellular response to hypoxia) 50.83%
- [GO:0060664](http://purl.obolibrary.org/obo/GO_0060664) (epithelial cell proliferation involved in salivary gland morphogenesis) 50.83%
- [GO:0044783](http://purl.obolibrary.org/obo/GO_0044783) (G1 DNA damage checkpoint) 50.83%
- [GO:0042772](http://purl.obolibrary.org/obo/GO_0042772) (DNA damage response, signal transduction resulting in transcription) 50.83%
- [GO:0042771](http://purl.obolibrary.org/obo/GO_0042771) (intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator) 50.83%
- [GO:0038001](http://purl.obolibrary.org/obo/GO_0038001) (paracrine signaling) 50.83%
- [GO:0031571](http://purl.obolibrary.org/obo/GO_0031571) (mitotic G1 DNA damage checkpoint) 50.83%
- [GO:0008630](http://purl.obolibrary.org/obo/GO_0008630) (intrinsic apoptotic signaling pathway in response to DNA damage) 50.83%
- [GO:0006978](http://purl.obolibrary.org/obo/GO_0006978) (DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator) 50.83%
- [GO:0001666](http://purl.obolibrary.org/obo/GO_0001666) (response to hypoxia) 50.83%
- [GO:0044773](http://purl.obolibrary.org/obo/GO_0044773) (mitotic DNA damage checkpoint) and [GO:2000134](http://purl.obolibrary.org/obo/GO_2000134) (negative regulation of G1/S transition of mitotic cell cycle) 50.83%
- [GO:0044773](http://purl.obolibrary.org/obo/GO_0044773) (mitotic DNA damage checkpoint) and [GO:2000045](http://purl.obolibrary.org/obo/GO_2000045) (regulation of G1/S transition of mitotic cell cycle) 50.83%
- [GO:0044773](http://purl.obolibrary.org/obo/GO_0044773) (mitotic DNA damage checkpoint) and [GO:1902807](http://purl.obolibrary.org/obo/GO_1902807) (negative regulation of cell cycle G1/S phase transition) 50.83%
- [GO:0044773](http://purl.obolibrary.org/obo/GO_0044773) (mitotic DNA damage checkpoint) and [GO:1902806](http://purl.obolibrary.org/obo/GO_1902806) (regulation of cell cycle G1/S phase transition) 50.83%


